Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockUpcoming Result Date: May 26, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Deep Health AI India Ltd (DDIL) is currently trading at 2.33 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Deep Diamond India Limited is primarily engaged in the business of rough and polished diamonds, as well as the sale and trading of diamond-studded and gold jewelry. The company has diversified its business portfolio by entering the consultancy services sector for the pharmaceutical industry starting from the financial year 2022-23. The diamond and jewelry business remains the core aspect of Deep Diamond India Limited's operations, reflecting its long-standing presence in the sector since 1994. While known for its expertise in the gem and jewelry industry, the company's recent diversification into pharmaceutical consultancy marks a strategic business shift.
Over the past 52 weeks, Deep Health AI India Ltd has traded between a low of ₹1.65 and a high of ₹10.29. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Deep Health AI India Ltd has a market capitalization of approximately 32.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Deep Health AI India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5.50 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 32.87 Cr, Deep Health AI India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Deep Health AI India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Deep Health AI India Ltd is 5.50. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
4
Neutral
7
Bullish
3
Bearish
22
Neutral
7
Bullish
17
Bearish
18
Neutral
0
Bullish
14
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
34.24 | 38 Cr | 69.59 | 0.41 | 0.00 | 0.67 | 1.26 | 0.57 | ||
2.31 | 36 Cr | 129.32 | 0.50 | 0.00 | 0.62 | 0.84 | 0.35 | ||
2.28 | 33 Cr | 5.50 | 0.93 | 0.00 | 11.62 | 15.29 | 21.04 | ||
32.10 | 33 Cr | 8.64 | 1.21 | 0.00 | 12.49 | 12.30 | 5.85 | ||
1.58 | 31 Cr | 17.46 | 0.47 | 0.00 | 3.15 | 3.37 | 1.87 | ||
58.98 | 27 Cr | 90.90 | 1.36 | 0.00 | 1.49 | 1.66 | 1.40 | ||
2.13 | 27 Cr | 22.99 | 1.69 | 0.00 | 6.23 | 8.14 | 4.44 | ||
| Median: 7 Co. | — | 2.31 | 33 Cr | 22.99 | 0.93 | 0.00 | 3.15 | 3.37 | 1.87 |
Deep Diamond India Limited is primarily engaged in the business of rough and polished diamonds, as well as the sale and trading of diamond-studded and gold jewelry.
The company has diversified its business portfolio by entering the consultancy services sector for the pharmaceutical industry starting from the financial year 2022-23.
The diamond and jewelry business remains the core aspect of Deep Diamond India Limited's operations, reflecting its long-standing presence in the sector since 1994.
While known for its expertise in the gem and jewelry industry, the company's recent diversification into pharmaceutical consultancy marks a strategic business shift.
Consumer Durables
Gems, Jewellery And Watches
34 Cr
Low Risk
5.6
48.0
0.1
0.9
10.29
1.65
Sales CAGR
Profit CAGR
ROE
ROCE
